FDA approval for Zurnai Auto-Injector: A new weapon in the fight against opioid overdose

FDA approval for Zurnai Auto-Injector: A new weapon in the fight against opioid overdose

In a major development in the battle against the opioid epidemic, Purdue Pharma’s Zurnai Auto-Injector has been granted approval by the US Food and Drug Administration (FDA) for the emergency treatment of opioid overdose. This approval marks a significant step forward in public health efforts to combat the rising tide of opioid-related deaths across the […]

Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer

Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer

Indian pharmaceutical company Lupin announced that Dr. Shahin Fesharaki has been appointed as Global Chief Scientific Officer who will handle global research and development works across generics, branded, and specialty products. Vinita Gupta – Lupin CEO and Lupin MD Nilesh Gupta said: “We are very pleased to welcome Shahin to our leadership team. Shahin’s exceptional […]

Glenmark gets marketing approval for Ryaltris in 13 European countries

Glenmark gets marketing approval for Ryaltris in 13 European countries

Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13 countries across the European Union (EU) and the UK. Ryaltris (olopatadine 665 µg and mometasone furoate 25 µg) has approval for the symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children, aged over 12. […]

Bio-Thera, Hikma Pharmaceuticals sign $150m licensing deal for BAT2206

Bio-Thera, Hikma Pharmaceuticals sign $150m licensing deal for BAT2206

Chinese biopharma company Bio-Thera Solutions has signed a commercialization and license deal worth up to $150 million with Hikma Pharmaceuticals to commercialize the former’s BAT2206. BAT2206 is a monoclonal antibody, which is being developed by the UK-based pharma company as a biosimilar referencing Jansen’s Stelara (ustekinumab), in the US. Stelara is presently approved for the […]